Ten years ago, in May 2005, world-renowned biostatistician Marvin Zelen was asked to deliver a keynote address before the Eastern Mediterranean Region of the Biometric Society. His address, entitled ‘Biostatisticians, Biostatistical Science and the Future,’  offered a reflection on the direction which the field at large would have to take, given the anticipated leaps in software and the...
‘A blend of courage and foolhardiness’: Marvin Zelen's 8 Predictions for the Future of Biostatistical Sciences
May 14, 2015 3:32:00 PM
Nov 17, 2014 3:57:00 PM
Outstanding Thought Leader, Scientist and Humanitarian, Passes away at Age 87
It is with immense sadness that we announce that Marvin Zelen, one of the foremost statisticians of our time, widely regarded as the Father of Clinical Trials, and mentor to hundreds of younger colleagues passed away on November 15, 2014. Professor Zelen was the former Chairman of the Department of Biostatistics at...
Topics: Marvin Zelen
Jul 24, 2014 1:30:00 PM
This is the third post in a three part series in which we consider (i) improvements to trial quality that result from bundling data management with biostatistics, (ii) reductions in cost and study length that result from bundling data management with biostatistics, and (iii) the contributions of statistical innovation to clinical data management, such as those by Cytel Board member Professor...
May 29, 2014 9:58:00 AM
Cytel has taken the initiative to train the next generation of clinical programmers through its innovative Clinnical Programming Laboratory [see Cytel's CliPLab].
What about training the next generation of statisticians? The Harvard School of Public Health has just awarded the 2014 Marvin Zelen Leadership Award in Statistical Sciences to a distinguished statistician and educator.
Apr 21, 2014 3:57:00 PM
The core methodological problem that would eventually spur the development of Cytel’s StatXact software was first posed by Harvard’s Marvin Zelen at a computational seminar in the late 1970s. Zelen, a distinguished professor of statistical sciences and head of the Department of Biostatistics at Harvard University, was also serving as the Director of the Dana Farber Cancer Institute.